309 related articles for article (PubMed ID: 10910421)
1. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
[TBL] [Abstract][Full Text] [Related]
2. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
3. Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomized trial.
Weber E; Stack J; Pollock BG; Mulsant B; Begley A; Mazumdar S; Reynolds CF3rd
Am J Geriatr Psychiatry; 2000; 8(3):245-50. PubMed ID: 10910424
[TBL] [Abstract][Full Text] [Related]
4. Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients.
Mamo DC; Pollock BG; Mulsant B; Houck PR; Bensasi S; Miller MC; Redfern MS; Reynolds III CF
Am J Geriatr Psychiatry; 2002; 10(2):199-205. PubMed ID: 11925281
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial of antidepressants in patients with Parkinson disease and depression.
Menza M; Dobkin RD; Marin H; Mark MH; Gara M; Buyske S; Bienfait K; Dicke A
Neurology; 2009 Mar; 72(10):886-92. PubMed ID: 19092112
[TBL] [Abstract][Full Text] [Related]
6. Treatment of depression in patients with heart disease.
Roose SP; Spatz E
J Clin Psychiatry; 1999; 60 Suppl 20():34-7. PubMed ID: 10513857
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly.
Bump GM; Mulsant BH; Pollock BG; Mazumdar S; Begley AE; Dew MA; Reynolds CF
Depress Anxiety; 2001; 13(1):38-44. PubMed ID: 11233459
[TBL] [Abstract][Full Text] [Related]
8. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.
Mulsant BH; Pollock BG; Nebes RD; Miller MD; Little JT; Stack J; Houck PR; Bensasi S; Mazumdar S; Reynolds CF
J Clin Psychiatry; 1999; 60 Suppl 20():16-20. PubMed ID: 10513853
[TBL] [Abstract][Full Text] [Related]
9. A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients.
Mulsant BH; Pollock BG; Nebes R; Miller MD; Sweet RA; Stack J; Houck PR; Bensasi S; Mazumdar S; Reynolds CF
Am J Geriatr Psychiatry; 2001; 9(4):406-14. PubMed ID: 11739067
[TBL] [Abstract][Full Text] [Related]
10. Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder.
Yeragani VK; Rao R
J Psychosom Res; 2003 Dec; 55(6):507-13. PubMed ID: 14642980
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients.
Laghrissi-Thode F; Pollock BG; Miller MC; Mulsant BH; Altieri L; Finkel MS
Psychopharmacol Bull; 1995; 31(4):659-63. PubMed ID: 8851637
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.
Pollock BG; Laghrissi-Thode F; Wagner WR
J Clin Psychopharmacol; 2000 Apr; 20(2):137-40. PubMed ID: 10770450
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
[TBL] [Abstract][Full Text] [Related]
15. Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.
Lanza di Scalea T; Hanusa BH; Wisner KL
J Clin Psychiatry; 2009 Mar; 70(3):423-8. PubMed ID: 19284932
[TBL] [Abstract][Full Text] [Related]
16. An imperfect literature and evidence-based medicine.
Freeman MP
J Clin Psychiatry; 2009 Mar; 70(3):412-3. PubMed ID: 19317958
[No Abstract] [Full Text] [Related]
17. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.
Nelson JC; Kennedy JS; Pollock BG; Laghrissi-Thode F; Narayan M; Nobler MS; Robin DW; Gergel I; McCafferty J; Roose S
Am J Psychiatry; 1999 Jul; 156(7):1024-8. PubMed ID: 10401446
[TBL] [Abstract][Full Text] [Related]
18. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder.
Yeragani VK; Pohl R; Jampala VC; Balon R; Ramesh C; Srinivasan K
Depress Anxiety; 2000; 11(3):126-30. PubMed ID: 10875054
[TBL] [Abstract][Full Text] [Related]
19. Elevation of nortriptyline plasma levels after cotreatment with paroxetine and thioridazine.
Ghaemi SN; Kirkwood CK
J Clin Psychopharmacol; 1998 Aug; 18(4):342-3. PubMed ID: 9690702
[No Abstract] [Full Text] [Related]
20. Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.
Solai LK; Pollock BG; Mulsant BH; Frye RF; Miller MD; Sweet RA; Kirshner M; Sorisio D; Begley A; Reynolds CF
J Clin Psychopharmacol; 2002 Oct; 22(5):481-6. PubMed ID: 12352271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]